See All Slides - tctmd.com

Slides

Presentation TCT 2012

Case Presentation with Discussion(9)

Presenter: Rogerio Sarmento-Leite

October 22, 2012

Presentation TCT 2012

Clinical Pearls from Experienced Valve-in-Valve Operators: Self-Expanding TAVR for Aortic Valve-in-Valve

Presenter: Jean-Claude Laborde

October 22, 2012

Presentation TCT 2012

Imaging Studies of Late Restenosis and/or Stent Thrombosis: Is Neoatherosclerosis the Final Common Pathway of DES Failure?

Presenter: Soo-Jin Kang

October 22, 2012

Presentation TCT 2012

Top 5 Blue-sky Wish List for CAS Device Improvements

Presenter: Daniel McCormick

October 22, 2012

Presentation TCT 2012

Taped Case 4: Complex Pelvic Reconstruction: Endovascular Treatment of Benign Prostatic Hypertrophy and Erectile Dysfunction

Presenter: Akaki Archvadze

October 22, 2012

Presentation TCT 2012

TAXUS: Final Five-Year SYNTAX Results (Entire Study Population)

Presenter: Patrick Serruys

October 22, 2012

Presentation TCT 2012

Should the AUC Criteria Dominate How We Select Patients for PCI?

Presenter: Paul Teirstein

October 22, 2012

Presentation TCT 2012

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

Choice of Antiplatelet Therapies in ACS/STEMI

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

REDUCE Trial Update

Presenter: John Rhodes

October 22, 2012

Advertisement

Slides

Case Presentation with Discussion(9)

Clinical Pearls from Experienced Valve-in-Valve Operators: Self-Expanding TAVR for Aortic Valve-in-Valve

Imaging Studies of Late Restenosis and/or Stent Thrombosis: Is Neoatherosclerosis the Final Common Pathway of DES Failure?

Top 5 Blue-sky Wish List for CAS Device Improvements

Taped Case 4: Complex Pelvic Reconstruction: Endovascular Treatment of Benign Prostatic Hypertrophy and Erectile Dysfunction

TAXUS: Final Five-Year SYNTAX Results (Entire Study Population)

Should the AUC Criteria Dominate How We Select Patients for PCI?

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

Choice of Antiplatelet Therapies in ACS/STEMI

REDUCE Trial Update

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content